CTI BIO has a total of 19 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Israel, Republic of Korea and United States. Its main competitors in its focus markets organic fine chemistry, biotechnology and pharmaceuticals are SHANGHAI DESANO PHARMACEUTICAL, FARMAK and HOECHST SA LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 4 | |
#2 | Republic of Korea | 3 | |
#3 | United States | 3 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Mexico | 1 | |
#10 | New Zealand | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Biotechnology | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Heterocyclic compounds | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Chung Shin | 14 |
#2 | Lee Jong-Ook | 11 |
#3 | Park Hyun-Jin | 11 |
#4 | Kim Mi-Ran | 11 |
#5 | Kim Heui-Yeon | 11 |
#6 | Lee Jong Ook | 2 |
#7 | Park Hyun Jin | 2 |
#8 | Kim Heui Yeon | 2 |
#9 | Shin Chung | 1 |
#10 | Kim Mi Ran | 1 |
Publication | Filing date | Title |
---|---|---|
KR20110087436A | Scn9a antisense oligonucleotide | |
KR20090098710A | Peptide nucleic acid derivatives with good cell penetration and affinity for nucleic acid |